Last update 12 Sep 2024
Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )
Last update 12 Sep 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms- |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD22 inhibitors(CD22 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Related
1
Clinical Trials associated with Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )Autologous Immunotherapy With Multi-target Gene-modified CAR-T/TCR-T Cell for Malignancies
100 Clinical Results associated with Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )
Login to view more data
100 Translational Medicine associated with Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )
Login to view more data
100 Patents (Medical) associated with Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )
Login to view more data
100 Deals associated with Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology )
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CD19-positive B-cell acute lymphoblastic leukemia | Phase 2 | CN | - | 01 Mar 2018 |
| Colorectal Cancer | Phase 2 | CN | - | 01 Mar 2018 |
| Esophageal Carcinoma | Phase 2 | CN | - | 01 Mar 2018 |
| Glioma | Phase 2 | CN | - | 01 Mar 2018 |
| Hepatocellular Carcinoma | Phase 2 | CN | - | 01 Mar 2018 |
| Lung Cancer | Phase 2 | CN | - | 01 Mar 2018 |
| Melanoma | Phase 2 | CN | - | 01 Mar 2018 |
| Mesothelioma | Phase 2 | CN | - | 01 Mar 2018 |
| Multiple Myeloma | Phase 2 | CN | - | 01 Mar 2018 |
| Myeloid Leukemia | Phase 2 | CN | - | 01 Mar 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free